Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery.

05:48 EST 19th December 2014 | BioPortfolio

Summary of "Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery."

Lipid nanoparticles based on solid matrix have emerged as potential drug carriers to improve gastrointestinal (GI) absorption and oral bioavailability of several drugs, especially lipophilic compounds. These formulations may also be used for sustained drug release. Solid lipid nanoparticle (SLN) and the newer generation lipid nanoparticle, nanostructured lipid carrier (NLC), have been studied for their capability as oral drug carriers. Biodegradable, biocompatible, and physiological lipids are generally used to prepare these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation efficiency of the nanoparticles was documented. Oral absorption and bioavailability of several drugs were improved after oral administration of the drug-loaded SLNs or NLCs. In this review, pros and cons, different formulation and characterization techniques, drug incorporation models, GI absorption and oral bioavailability enhancement mechanisms, stability and storage condition of the formulations, and recent advances in oral delivery of the lipid nanoparticles based on solid matrix will be discussed.

Affiliation

Institute of Chemical and Engineering Sciences, Agency for Science, Technology and Research, 1 Pesek Road, Jurong Island, Singapore, 627833, Republic of Singapore, surajit_das@ices.a-star.edu.sg.

Journal Details

This article was published in the following journal.

Name: AAPS PharmSciTech
ISSN: 1530-9932
Pages:

Links

PubMed Articles [18046 Associated PubMed Articles listed on BioPortfolio]

Influence of co-surfactants on crystallization and stability of solid lipid nanoparticles.

The purpose of this study was to find a suitable co-surfactant to replace non-food grade bile salts in solid lipid nanoparticle (SLN) formulations. The hypothesis was that the molecular structure and ...

Nanoparticle Drug Formulations for Cancer Diagnosis and Treatment.

Over the past ten years, more than a billion dollars in U.S. government funding has been awarded to the development of nanomaterials for clinical diagnosis and therapy. In this article we will focus o...

Annotating the structure and components of a nanoparticle formulation using computable string expressions.

Nanoparticle formulations that are being developed and tested for various medical applications are typically multi-component systems that vary in their structure, chemical composition, and function. I...

Development of Lipid Nanoparticle Formulations of siRNA for Hepatocyte Gene Silencing Following Subcutaneous Administration.

Recently developed lipid nanoparticle (LNP) formulations of siRNA have proven to be effective agents for hepatocyte gene silencing following intravenous administration with at least three LNP-siRNA fo...

Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.

Abstract Inflammation and the presence of pro-inflammatory cytokines are associated with numerous chronic diseases such as type-2 diabetes mellitus, cardiovascular disease, Alzheimer's disease, and ca...

Clinical Trials [3020 Associated Clinical Trials listed on BioPortfolio]

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation and gemcitabine, work in different ways to stop the growth of tumor cells, either by k...

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors

RATIONALE: Drugs used in chemotherapy such as paclitaxel albumin-stabilized nanoparticle formulation and carboplatin work in different ways to stop the growth of tumor cells, either by kil...

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by killing the cells...

Fentanyl Matrix in Lung Cancer Pain

The purpose of this study is to evaluate the usefulness of fentanyl matrix by assessing patients' satisfaction when administrating fentanyl matrix, a background pain treatment, and a break...

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by killing the cells...

Medical and Biotech [MESH] Definitions

Educational programs designed to inform nurses of recent advances in their fields.

Educational programs designed to inform dentists of recent advances in their fields.

Educational programs designed to inform physicians of recent advances in their field.

Educational programs designed to inform graduate pharmacists of recent advances in their particular field.

Educational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing.

Search BioPortfolio:
Loading